Department of Obstetrics and Gynaecology


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Mammographic density and prognosis in primary breast cancer patients (2021) Heindl F, Fasching P, Hein A, Hack C, Heusinger K, Gaß P, Pöschke P, et al. Journal article Digital Maternity Records: Motivation, Acceptance, Requirements, Usability and Prototype Evaluation of an Interface for Physicians and Midwives (2021) Dörflinger L, Nissen M, Jäger K, Wirth M, Titzmann A, Pontones C, Fasching P, et al. Conference contribution, Original article Metastatic cervical carcinoma: adenocarcinoma = squamous cell carcinoma? (2021) Hein A Conference contribution Reproducibility of mRNA-Based Testing of ESR1, PGR, ERBB2, and MKI67 Expression in Invasive Breast Cancer-A Europe-Wide External Quality Assessment (2021) Erber R, Hartmann A, Fasching P, Rübner M, Stöhr R, Beckmann M, Zentgraf M, et al. Journal article Pattern of invasion in stage I mucinous ovarian cancer is prognostic within 2-years of diagnosis (2021) Meagher N, Koebel M, Anderson L, Tan A, Bolithon A, Anglesio M, Cohen P, et al. Conference contribution PCL micro-dumbbells - A new class of polymeric particles reveals morphological biofunctionality (2021) Sonnleitner D, Schaefer N, Wieland A, Fischer L, Pasberg P, Thievessen I, Lang G Journal article Procoagulant extracellular vesicles alter trophoblast differentiation in mice by a thrombo-inflammatory mechanism (2021) Markmeyer P, Lochmann F, Singh KK, Gupta A, Younis R, Shahzad K, Biemann R, et al. Journal article Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer (2021) Quinn MC, McCue K, Shi W, Johnatty SE, Beesley J, Civitarese A, O'Mara TA, et al. Journal article KEYNOTE-522: Phase III study of neoadjuvant pembrolizumab D chemotherapy vs. placebo D chemotherapy, followed by adjuvant pembrolizumab vs. placebo for earlystage TNBC (2021) Schmid P, Cortes J, Dent R, Pusztai L, Mcarthur H, Kummel S, Bergh J, et al. Conference contribution Prognostic effect of low-level HER2 expression in patients with clinically negative HER2 status (2021) Hein A, Hartkopf AD, Emons J, Lux MP, Volz B, Taran FA, Overkamp F, et al. Journal article